Correlation Between Ascletis Pharma and Therapeutic Solutions

Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Therapeutic Solutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Therapeutic Solutions into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascletis Pharma and Therapeutic Solutions International, you can compare the effects of market volatilities on Ascletis Pharma and Therapeutic Solutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Therapeutic Solutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Therapeutic Solutions.

Diversification Opportunities for Ascletis Pharma and Therapeutic Solutions

0.06

Correlation Coefficient

Ascletis Pharma  Therapeutic Solutions

Significant diversification

The 3 months correlation between Ascletis and Therapeutic is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Therapeutic Solutions Internat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Therapeutic Solutions and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Therapeutic Solutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Therapeutic Solutions has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Therapeutic Solutions go up and down completely randomly.

Pair Corralation between Ascletis Pharma and Therapeutic Solutions

Assuming the 90 days horizon Ascletis Pharma is expected to generate 10.78 times less return on investment than Therapeutic Solutions. But when comparing it to its historical volatility, Ascletis Pharma is 3.02 times less risky than Therapeutic Solutions. It trades about 0.01 of its potential returns per unit of risk. Therapeutic Solutions International is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.10  in Therapeutic Solutions International on September 4, 2024 and sell it today you would lose (0.05) from holding Therapeutic Solutions International or give up 50.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	99.6%
Values	Daily Returns

Ascletis Pharma  vs.  Therapeutic Solutions Internat

Ascletis Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Therapeutic Solutions

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Therapeutic Solutions International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Therapeutic Solutions is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Ascletis Pharma and Therapeutic Solutions

The main advantage of trading using opposite Ascletis Pharma and Therapeutic Solutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Therapeutic Solutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Therapeutic Solutions will offset losses from the drop in Therapeutic Solutions' long position.

The idea behind Ascletis Pharma and Therapeutic Solutions International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.